Topigen Pharmaceuticals
- Website
- topigen.com
- Total Funding
- $25.0M
- Last Round
- $25.0M Series C
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Topigen Pharmaceuticals is a Biotech company. It has raised $25.0M in total across 1 round. Investors include BDC Capital, NovaQuest and Fonds de solidarite FTQ.
Funding History
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/topigen-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/topigen-pharmaceuticals" alt="Topigen Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>